Healthcare

M&A Economy & Policy Capital Markets

Anti-trust agency CADE imposes no restrictions on the acquisition of the medical services company by Nelson Tanure's investment firm

Loans Debt Healthcare

Uruguayan pharmaceutical company borrows $130 mln in a deal arranged by the local branch of Itaú

Corporate & Sovereign Strategy Equity M&A

Brazilian hospital network agrees to pay $45 mln for Hospital Premium in state capital Goiânia

Corporate & Sovereign Strategy Equity M&A

Well-capitalized groups and investment funds have sustained M&A activity in 2021, but cross-border deals are declining, Deloitte says

Corporate & Sovereign Strategy International Financial Institutions World Bank

South American country gets $68 mln to improve its response to public health emergencies

Brazil People Healthcare

Paulo Nigro will run the Brazilian hospital network alongside Fernando Ganem

Corporate & Sovereign Strategy Equity IPO

Brazilian for-profit education company plots a course for the stock market after agreeing to sell 25% of its medical division to DNA Capital for $178 mln

Corporate & Sovereign Strategy Equity M&A

Brazilian asset management company could end up spending $411 mln to buy the medical services company, analyst says

Corporate & Sovereign Strategy Equity M&A

Brazilian healthcare company agrees to pay $55 mln for a hospital and a medical imaging center in Minas Gerais as part of its expansion plans

International Financial Institutions Economy & Policy Funds

Mexico has no need to tap a $50 bln FCL because it has enough reserves to face a crisis, analyst says

Corporate & Sovereign Strategy Equity M&A

Nelson Tanure's asset management firm increases its offer to buy the Brazilian medical services group

Debt Funds Latin America

Mexican pharmaceutical company forms a JV with Israel's Oramed to make and market oral COVID-19 vaccines in Latin America

Debt Loans Economy & Policy

US-based development bank lends $800 mln to Colombia and $500 mln to Ecuador along with a $400 mln contingency loan to Guatemala

Corporate & Sovereign Strategy Equity M&A

Belo Horizonte-based medical diagnostics company agrees to pay $18 mln for 60% of IACS with the option to buy the other 40% in five years

Corporate & Sovereign Strategy Equity M&A

Brazilian medical supplies company has spent around $185 mln on M&A so far, source says